Synlogic Announces First Quarter 2019 Conference Call and Webcast

Synlogic Presents Data Describing a Solid Oral Formulation Process for Synthetic Biotic™ Medicine SYNB1618 for the Treatment of PKU at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Synlogic to Present Data from New Solid Oral Formulation Process at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Synlogic Appoints Scott Plevy M.D. as Chief Scientific Officer

Synlogic to Webcast Presentation at the 18th Annual Needham Healthcare Conference

Synlogic to Webcast Presentation at the Oppenheimer 29th Annual Healthcare Conference

Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

Synlogic Announces Achievement of Milestone in Collaboration to Develop Synthetic Biotic™ Medicines to Treat Inflammatory Bowel Disease

Synlogic Announces Fourth Quarter and Full Year 2018 Conference Call and Webcast

Synlogic to Present at Investor Conferences in March

Synlogic to Webcast Presentation at the SVB Leerink 8th Annual Global Healthcare Conference

Synlogic Appoints Patricia N. Hurter, Ph.D. to Board of Directors